Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic …
A Osterborg, MJ Dyer, D Bunjes… - Journal of Clinical …, 1997 - ascopubs.org
PURPOSE CAMPATH-1H is a human immunoglobulin G1 (IgG1) anti-CD52 monoclonal
antibody (MAb) that binds to nearly all B- and T-cell lymphomas and leukemias. We report the …
antibody (MAb) that binds to nearly all B- and T-cell lymphomas and leukemias. We report the …
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell …
…, B Hertenstein, E Mischak-Weissinger, D Bunjes… - Blood, 2006 - ashpublications.org
A sequential regimen of chemotherapy, reduced-intensity conditioning (RIC) for allogeneic
stem cell transplantation (SCT), and prophylactic donor lymphocyte transfusion (pDLT) was …
stem cell transplantation (SCT), and prophylactic donor lymphocyte transfusion (pDLT) was …
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL …
…, R Busch, S Dietrich, D Bunjes… - Blood, The Journal …, 2010 - ashpublications.org
The purpose of this prospective multicenter phase 2 trial was to investigate the long-term
outcome of reduced-intensity conditioning allogeneic stem cell transplantation (alloSCT) in …
outcome of reduced-intensity conditioning allogeneic stem cell transplantation (alloSCT) in …
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in …
…, F Aversa, JM Rowe, D Bunjes… - Blood, The Journal …, 2008 - ashpublications.org
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is an alternative
treatment to patients with high-risk acute leukemia lacking a human leukocyte antigen-matched …
treatment to patients with high-risk acute leukemia lacking a human leukocyte antigen-matched …
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the …
…, A Gratwohl, DW Beelen, D Bunjes… - Blood, The Journal …, 2010 - ashpublications.org
The role of allogeneic stem cell transplantation in chronic myeloid leukemia is being reevaluated.
Whereas drug treatment has been shown to be superior in first-line treatment, data on …
Whereas drug treatment has been shown to be superior in first-line treatment, data on …
[HTML][HTML] Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow …
Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT)
remains a major therapeutic challenge. We studied outcomes of 1788 AML patients …
remains a major therapeutic challenge. We studied outcomes of 1788 AML patients …
[HTML][HTML] Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an …
…, MS Tallman, JF DiPersio, D Bunjes… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Purpose Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders that are
more common in patients aged≥ 60 years and are incurable with conventional therapies. …
more common in patients aged≥ 60 years and are incurable with conventional therapies. …
[PDF][PDF] Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia
…, R Schwerdtfeger, M Eder, D Bunjes… - Journal of Clinical …, 2009 - researchgate.net
Purpose Reduced intensity conditioning regimen (RIC) is increasingly used in hematopoietic
stem cell transplantation (HSCT). Unrelated donor (UD) transplants have more …
stem cell transplantation (HSCT). Unrelated donor (UD) transplants have more …
2‐(fluorine‐18)fluoro‐2‐deoxy‐D‐glucose positron emission tomography in the detection and staging of malignant lymphoma: A bicenter trial
I Buchmann, M Reinhardt, K Elsner, D Bunjes… - Cancer, 2001 - Wiley Online Library
BACKGROUND The authors undertook a prospective evaluation of the clinical value of 2‐fluoro
[18‐]‐2‐deoxyglucose positron emission tomography (FDG‐PET) in the detection and …
[18‐]‐2‐deoxyglucose positron emission tomography (FDG‐PET) in the detection and …
Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic …
…, S von Harsdorf, H Döhner, E Seifried, D Bunjes… - …, 2011 - Wiley Online Library
BACKGROUND: Cytomegalovirus (CMV) disease constitutes a serious complication after
allogeneic stem cell transplantation. For the clearance of CMV, CD8+ T cells are pivotal. …
allogeneic stem cell transplantation. For the clearance of CMV, CD8+ T cells are pivotal. …